Cite
HARVARD Citation
Onali, S. et al. (n.d.). T.06.1 CROHN'S DISEASE PATIENTS WITH USTEKINUMAB-INDUCED REMISSION ARE CHARACTERIZED BY HIGH BASELINE IL23 RECEPTOR EXPRESSION IN THE LAMINA PROPRIA TH1 CELLS. Digestive and liver disease. pp. S159-. [Online].